# Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age

> **NCT02123134** · PHASE3 · COMPLETED · sponsor: **Kythera Biopharmaceuticals** · enrollment: 55 (actual)

## Conditions studied

- Moderate to Severe Convexity of Submental Fat
- Safety
- Efficacy

## Interventions

- **DRUG:** ATX-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02123134
- **Lead sponsor:** Kythera Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02123134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02123134, "Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02123134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*